Literature DB >> 3886212

Hepatic circulation in cirrhosis.

P M Huet, J P Villeneuve, G Pomier-Layrargues, D Marleau.   

Abstract

Using the multiple indicator dilution approach, events occurring in the microvascular bed can be characterized and are compatible with the two kinds of anatomical alterations in cirrhotic livers: capillarization and intrahepatic shunts. The combination of these two kinds of alteration contributes to the progressive limitation of the blood-liver exchange. The decreased ability of the liver to clear endogenous and exogenous substrates in cirrhosis is generally thought to result from a reduction of liver cell mass and/or function. Our data suggest that abnormalities in the hepatic uptake of these substrates may also contribute to the impaired liver function in cirrhosis. Capillarization of the hepatic sinusoid is of particular importance in the overall process of elimination while intrahepatic shunts, when present, further exacerbate the functional effects of capillarization.

Entities:  

Mesh:

Year:  1985        PMID: 3886212

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


  9 in total

Review 1.  The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance.

Authors:  David G Le Couteur; Robin Fraser; Sarah Hilmer; Laurent P Rivory; Allan J McLean
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Hepatic hemodynamic changes during liver transplantation: a review.

Authors:  An-Chieh Feng; Hsiu-Lung Fan; Teng-Wei Chen; Chung-Bao Hsieh
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

3.  Hepatic extraction of morphine is impaired in cirrhosis.

Authors:  B Crotty; K J Watson; P V Desmond; M L Mashford; L J Wood; J Colman; F J Dudley
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Arterial-venous shunting in liver cirrhosis.

Authors:  G Molino; F Bar; S Battista; M Torchio; A G Niro; E Garello; P Avagnina; C Fava; M Grosso; F Spalluto
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

5.  Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease.

Authors:  Nicole L Ward; Alexandra L Haninec; Paul Van Slyke; John G Sled; Celina Sturk; R Mark Henkelman; Ian R Wanless; Daniel J Dumont
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.

Authors:  Ivan Chebib; Meer Taher Shabani-Rad; Michelle S Chow; James Zhang; Zu-Hua Gao
Journal:  Biomark Insights       Date:  2007-02-14

7.  Location and function of intrahepatic shunts in anaesthetised rats.

Authors:  X Li; I S Benjamin; R Naftalin; B Alexander
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

8.  Mononuclear phagocyte system responsiveness in CCl4-induced liver cirrhosis.

Authors:  D N Mayanski; Y S Schwartz; S N Kutina; A A Zubakhin; N N Mayanskaya; D D Tsyrendorjiev
Journal:  Int J Exp Pathol       Date:  1993-06       Impact factor: 1.925

Review 9.  Hepatic circulation: potential for therapeutic intervention.

Authors:  F Ballet
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.